Association between sodium-glucose cotransporter-2 (SGLT2) inhibitors and macular degeneration in patients with diabetes: a nationwide population-based study in Taiwan.

Min-Yen HsuKai-Shin LuoChien-Chih ChouYu-Hsiang LinYu-Chien HungWu-Lung ChuangStella Chin-Shaw TsaiHeng-Jun LinTeng-Shun YuFuu-Jen TsaiKuang-Hsi Chang

Published in: Acta diabetologica (2024)

We found that SGLT2is has a strong protective effect against MD in patients with diabetes. SGLT2is may have benefits beyond glycemic control in patients with DR. However, additional clinical and experimental studies are required.

Keyphrases

glycemic control
type diabetes
blood glucose
optical coherence tomography
weight loss
insulin resistance
case control
metabolic syndrome